Statistics for Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study
Total visits
views | |
---|---|
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study | 133 |
Total visits per month
views | |
---|---|
December 2024 | 6 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation.pdf(legacy) | 330 |
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation.pdf | 3 |
Top country views
views | |
---|---|
United States | 58 |
China | 24 |
Germany | 13 |
France | 11 |
Portugal | 8 |
Canada | 4 |
Netherlands | 3 |
Ukraine | 2 |
United Kingdom | 1 |
Hong Kong SAR China | 1 |
Ireland | 1 |
Iran | 1 |
Italy | 1 |
Mexico | 1 |
South Africa | 1 |